Posted by: Georgia Retina in Uncategorized
Board Certified Retina Specialists Offer Optometrists Updates on Commonly Encountered Retinal Problems
Optometrists will learn about new research regarding the genetics of age-related macular degeneration (AMD) and updates on diagnosing commonly encountered retinal problems at the February/March PEARLS seminar hosted by Georgia Retina, the state’s largest retina-only private practice.
Scheduled for Feb. 28 and March 1, the free event at Maggianos in Buckhead is open to optometrists in Georgia and qualifies attendees for 2.5 hours of continuing education credits.
While the Feb. 28 event is full, there is limited availability for the March 1 session. Optometrists can register by emailing [email protected].
Educational objectives of the program are to help attendees:
– Understand commonly encountered retinal problems, how they are diagnosed, when to refer them and how they are treated.
– Discuss the risk factors for advanced AMD and the new research regarding the genetics of AMD.
– Understand emerging treatments for neovascular age-related macular degeneration and the complexities involved with instituting initial care and ongoing treatment for the disease.
– Understand how OCT images are produced and how to interpret a variety of vitreoretinal pathology.
Georgia Retina hosts two PEARLS seminars each year as a service to optometrists in the region. Topics at the upcoming session and presenters include:
– Eye Q: A Georgia Retina Quiz Game by Michael Jacobson, M.D.
– Risk Factors for Advanced AMD: Is there a role for Genetic Testing? by Robert Stoltz, M.D., PhD
– What is Eylea™? by Stephanie Vanderveldt, M.D.
– Optical Coherence Tomography (OCT): Principles and Pathology by John Miller, M.D.
At Georgia Retina, patients’ vision needs are the top priority. As one of the largest retina-only medical practices in the southeastern United States, Georgia Retina specializes in treating diseases of the retina, macula, and vitreous. Its nine board-certified ophthalmologists have received special Fellowship training in vitreo-retinal diseases and surgery, and are engaged in clinical trials with the goal of advancing research into retinal diseases, their causes, and their cures.
